Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

Journal of Neuroimmunology

Volumn 239, Issue 1-2, 2011, Pages 87-90

  Kuwahara, Motoi ^a   Suzuki, Seiko ^a   Takada, Kazuo ^a   Kusunoki, Susumu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AIDP; CIDP; Demyelination; Ganglioside complex; GBS; LM1

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE LM1; GANGLIOSIDE LM1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROPREVALENCE;

AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; MALE; MYELIN SHEATH; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PROTEIN TRANSPORT;

EID: 80054891677     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.08.016     Document Type: Article

References (21)

1. Allen D., Giannopoulos K., Gray I., Gregson N., Makowska A., Pritchard J., Hughes R.A. Antibodies to peripheral nerve myelin proteins in cronic inflammatory demyelinating polyradicuroneuropathy. J. Peripher. Nerv. Syst. 2005, 10:174-180.
2. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 1990, 27:S21-S24. (suppl).
3. Fredman P., Vedeler C.A., Nyland H., Aarli J.A., Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulfatide of peripheral nerve myelin. J. Neurol. 1991, 238:75-79.
4. Harukawa H., Utsumi H., Asano A., Yoshino H. Anti-LM1 antibodies in the sera of patients with Guillain-Barré syndrome, Miller Fisher syndrome, and motor neuron disease. J. Peripher. Nerv. Syst. 2002, 7:54-58.
5. Ho T.W., Mishu B., Li C.Y., Gao C.Y., Cornblath D.R., Griffin J.W., Asbury A.K., Blaser M.K., Mckhann G.M. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995, 118:597-605.
6. Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z., Cook S.D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and cronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 1992, 107:111-121.
7. Joint Task Force of the EFNS and the PNS European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. J. Peripher. Nerv. Syst. 2005, 10:220-228.
8. Kaida K., Morita D., Kanzaki M., Kamakura K., Motoyoshi K., Hirakawa M., Kusunoki S. Ganglioside complexes: as new target antigens in Guillain-Barré syndrome. Ann. Neurol. 2004, 56:567-571.
9. Kaida K., Kanzaki M., Morita D., Kamakura K., Motoyoshi K., Hirakawa M., Kusunoki S. Anti-ganglioside complex antibodies in Miller Fisher syndrome. J. Neurol. Neurosurg. Psychiatry 2006, 77:1043-1046.
10. Kaida K., Morita D., Kanzaki M., Kamakura K., Motoyoshi K., Hirakawa M., Kusunoki S. Anti-ganglioside complex antibodies associated with severe disability in GBS. J. Neuroimmunol. 2007, 182:212-218.
11. Kaida K., Sonoo M., Ogawa G., Kamakura K., Ueda-Sada M., Arita M., Motoyoshi K., Kusunoki S. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barré syndromes. Neurology 2008, 71:1683-1690.
12. Kanda T., Ariga T., Kubodera H., Jin H.L., Owada K., Kasama T., Yamawaki M., Mizusawa H. Glycosphingolipid composition of primary cultured human brain microvascular endothelial cells. J. Neurosci. Res. 2004, 78:141-150.
13. Kanzaki M., Kaida K., Ueda M., Morita D., Hirakawa M., Motoyoshi K., Kamakura K., Kusunoki S. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barré syndromes. J. Neurol. Neurosurg. Psychiatry 2008, 79:1148-1152.
14. Kusunoki S., Chiba A., Tai T., Kanazawa I. Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve 1993, 16:752-756.
15. Meléndez-Vásquez C., Redford J., Choudhary P.P., Gray I.A., Maitland P., Gregson N.A., Smith K.J., Hughes R.A. Immunological investigation of chronic inflammatory demyelinationg polyradiculoneuropathy. J. Neuroimmunol. 1997, 73:124-134.
16. Nobile-Orazio E., Giannotta C., Briani C. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies. J. Neuroimmunol. 2010, 219:119-122.
17. Ogawa G., Kaida K., Kusunoki S., Ueda M., Kimura F., Kamakura K. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes. J. Neuroimmunol. 2009, 214:125-127.
18. Ogawa-Goto K., Funamoto N., Ohta Y., Abe T., Nagashima K. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from Cauda equine. J. Neurochem. 1992, 59:1844-1849.
19. Susuki K., Yuki N., Hirata K., Kuwabara S. Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome. J. Neurol. Sci. 2002, 195:145-148.
20. Yako K., Kusunoki S., Kanazawa I. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. J. Neurol. Sci. 1999, 168:85-89.
21. Yan W.X., Archelos J.J., Hartung H.P., Pollard J.D. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol. 2001, 50:286-292.